Free Trial

Rhumbline Advisers Sells 7,337 Shares of Crocs, Inc. (NASDAQ:CROX)

Crocs logo with Consumer Discretionary background

Rhumbline Advisers cut its stake in Crocs, Inc. (NASDAQ:CROX - Free Report) by 4.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 151,862 shares of the textile maker's stock after selling 7,337 shares during the quarter. Rhumbline Advisers owned about 0.27% of Crocs worth $16,128,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Parallel Advisors LLC lifted its position in shares of Crocs by 26.5% during the first quarter. Parallel Advisors LLC now owns 630 shares of the textile maker's stock worth $67,000 after purchasing an additional 132 shares during the last quarter. GAMMA Investing LLC grew its stake in Crocs by 16,944.6% in the first quarter. GAMMA Investing LLC now owns 144,538 shares of the textile maker's stock valued at $15,350,000 after purchasing an additional 143,690 shares during the last quarter. Stonehearth Capital Management LLC acquired a new position in shares of Crocs during the first quarter valued at about $214,000. Fairtree Asset Management Pty Ltd acquired a new position in shares of Crocs during the fourth quarter valued at about $2,124,000. Finally, Wealth Enhancement Advisory Services LLC lifted its stake in shares of Crocs by 362.8% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 38,063 shares of the textile maker's stock worth $4,169,000 after buying an additional 29,839 shares during the period. 93.44% of the stock is currently owned by institutional investors.

Crocs Stock Performance

NASDAQ CROX opened at $101.46 on Friday. The stock has a market cap of $5.69 billion, a PE ratio of 6.35, a P/E/G ratio of 1.80 and a beta of 1.41. The company has a current ratio of 1.18, a quick ratio of 0.70 and a debt-to-equity ratio of 0.74. Crocs, Inc. has a twelve month low of $86.11 and a twelve month high of $165.32. The stock has a fifty day simple moving average of $101.69 and a 200-day simple moving average of $104.27.

Crocs (NASDAQ:CROX - Get Free Report) last posted its earnings results on Thursday, May 8th. The textile maker reported $3.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.51 by $0.49. Crocs had a return on equity of 46.27% and a net margin of 23.16%. The firm had revenue of $937.33 million for the quarter, compared to analyst estimates of $907.07 million. During the same quarter in the prior year, the company earned $3.02 EPS. Crocs's revenue was down .1% on a year-over-year basis. Equities analysts anticipate that Crocs, Inc. will post 13.2 earnings per share for the current year.

Insider Buying and Selling at Crocs

In other Crocs news, Director Ian Bickley sold 3,044 shares of the stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $115.89, for a total value of $352,769.16. Following the sale, the director now owns 27,505 shares of the company's stock, valued at $3,187,554.45. This trade represents a 9.96% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 3.00% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

CROX has been the topic of a number of recent research reports. Piper Sandler dropped their target price on Crocs from $125.00 to $115.00 and set an "overweight" rating on the stock in a research report on Friday, April 11th. Needham & Company LLC boosted their price target on Crocs from $118.00 to $129.00 and gave the company a "buy" rating in a report on Thursday, May 8th. Robert W. Baird reduced their target price on Crocs from $180.00 to $150.00 and set an "outperform" rating for the company in a research note on Monday, February 10th. Stifel Nicolaus reduced their price objective on Crocs from $138.00 to $127.00 and set a "buy" rating for the company in a research note on Thursday, April 10th. Finally, Barclays reduced their price objective on Crocs from $122.00 to $119.00 and set an "overweight" rating for the company in a research note on Friday, May 9th. Three research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company's stock. Based on data from MarketBeat, Crocs has an average rating of "Moderate Buy" and an average target price of $139.79.

Check Out Our Latest Stock Analysis on CROX

Crocs Company Profile

(Free Report)

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.

Read More

Want to see what other hedge funds are holding CROX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Crocs, Inc. (NASDAQ:CROX - Free Report).

Institutional Ownership by Quarter for Crocs (NASDAQ:CROX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Crocs Right Now?

Before you consider Crocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crocs wasn't on the list.

While Crocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines